ASCO GI 2023 Conference Coverage
M

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 Study: Durvalumab or Placebo + Gemcitabine & Cisplatin in Advanced Biliary Tract Cancer

By ASCO GI 2023 Conference Coverage FEATURING Mohamed Bouattour
By ASCO GI 2023 Conference Coverage FEATURING Mohamed Bouattour
304 views
January 28, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Recommended

27:37

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

4.1K views

·

1 year ago
22:33

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

369 views

·

7 months ago
28:25

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Integrity CE

V. Lee, E. Christenson, N. Bhagat, E. Winslow

252 views

·

7 months ago
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

375 views

·

5 months ago
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views

·

10 months ago
09:13

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

230 views

·

5 months ago
14:54

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

Insights from 2023 ESMO Annual Meeting

L. Rimassa

435 views

·

1 year ago
15:49

Updates in Targeted Therapies for Metastatic Biliary Tract Cancers

Integrity CE

J. Harding

191 views

·

7 months ago
11:27

Hepatic Arterial Infusion for Primary Liver Cancer

Integrity CE

K. Lafaro

164 views

·

7 months ago
21:46

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management…

Insights from 2023 ESMO Asia Annual Meeting

M. Ikeda

305 views

·

10 months ago
04:39

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infig…

Insights from 2024 ASCO® GI Annual Meeting

G. Abou-Alfa

172 views

·

9 months ago
06:51

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

91 views

·

4 months ago
05:46

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Penn Medicine Abramson Cancer Center

T. Karasic

302 views

·

1 year ago
10:28

ESMO GI 2024 Insights: Durvalumab + Chemo in Biliary Tract Cancer - …

Insights from 2024 ESMO GI Annual Meeting

D. Oh

87 views

·

4 months ago
18:35

Biliary Cancer Updates - 2023 ASCO® Direct Philadelphia

Total Health

D. Lin

190 views

·

1 year ago
09:05

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

AACR 2023 Conference Coverage

K. Kelley

352 views

·

1 year ago
12:38

ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Ca…

2024 ASCO® Annual Meeting Insights Hub

L. Goff

80 views

·

5 months ago
03:50

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -03 Cl…

Insights from 2023 ESMO Annual Meeting

A. Lamarca

175 views

·

1 year ago
06:42

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

ASCO 2022 Conference Coverage

G. Abou-Alfa

1.1K views

·

2 years ago
14:37

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Controlled D…

Insights from 2023 ASCO® Annual Meeting

A. Batra

172 views

·

1 year ago
AUTOPLAY